Skip to main content
. 2021 Jul 16;10(14):3146. doi: 10.3390/jcm10143146

Table 2.

Intolerance, suboptimal response, and failure to imatinib treatment according to the transcript type.

e13a2
(n = 76)
e14a2
(n = 126)
Total
(n = 202)
p Value
Intolerance, n (%) 12/76 (16) 22/126 (18) 34/202 (17) 0.758
Suboptimal Response, n (%) 13/76 (17) 19/126 (15) 32/202 (16) 0.702
Failure, n (%) 19/76 (25) 28/126 (22) 47/202 (23) 0.651